Literature DB >> 27981583

Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease.

Joyce Tran1, Dennis Chang1, Frederick Hsu1, Hongsu Wang1, Zhefeng Guo1.   

Abstract

Aβ42 is the major component of parenchymal plaques in the brain of Alzheimer's patients, while Aβ40 is the major component of cerebrovascular plaques. Since Aβ40 and Aβ42 coexist in the brain, understanding the interaction between Aβ40 and Aβ42 during their aggregation is important to delineate the molecular mechanism underlying Alzheimer's disease. Here, we present a rigorous and systematic study of the cross-seeding effects between Aβ40 and Aβ42. We show that Aβ40 fibril seeds can promote Aβ42 aggregation in a concentration-dependent manner, and vice versa. Our results also suggest that seeded aggregation and spontaneous aggregation may be two separate pathways. These findings may partly resolve conflicting observations in the literature regarding the cross-seeding effects between Aβ40 and Aβ42.
© 2016 Federation of European Biochemical Societies.

Entities:  

Keywords:  Amyloid; fibrillization kinetics; protein aggregation

Mesh:

Substances:

Year:  2016        PMID: 27981583      PMCID: PMC5235972          DOI: 10.1002/1873-3468.12526

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  49 in total

1.  Cross-seeding effects of amyloid β-protein and α-synuclein.

Authors:  Kenjiro Ono; Ryoichi Takahashi; Tokuhei Ikeda; Masahito Yamada
Journal:  J Neurochem       Date:  2012-07-23       Impact factor: 5.372

2.  A new structural model of Aβ40 fibrils.

Authors:  Ivano Bertini; Leonardo Gonnelli; Claudio Luchinat; Jiafei Mao; Antonella Nesi
Journal:  J Am Chem Soc       Date:  2011-09-21       Impact factor: 15.419

3.  Hydrogen-deuterium (H/D) exchange mapping of Abeta 1-40 amyloid fibril secondary structure using nuclear magnetic resonance spectroscopy.

Authors:  Neil A Whittemore; Rajesh Mishra; Indu Kheterpal; Angela D Williams; Ronald Wetzel; Engin H Serpersu
Journal:  Biochemistry       Date:  2005-03-22       Impact factor: 3.162

4.  Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

Authors:  S A Gravina; L Ho; C B Eckman; K E Long; L Otvos; L H Younkin; N Suzuki; S G Younkin
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

5.  Abeta40 protects non-toxic Abeta42 monomer from aggregation.

Authors:  Yilin Yan; Chunyu Wang
Journal:  J Mol Biol       Date:  2007-04-12       Impact factor: 5.469

6.  Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum.

Authors:  K Mak; F Yang; H V Vinters; S A Frautschy; G M Cole
Journal:  Brain Res       Date:  1994-12-19       Impact factor: 3.252

7.  Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

Authors:  Jun-Xia Lu; Wei Qiang; Wai-Ming Yau; Charles D Schwieters; Stephen C Meredith; Robert Tycko
Journal:  Cell       Date:  2013-09-12       Impact factor: 41.582

8.  Amylin-Aβ oligomers at atomic resolution using molecular dynamics simulations: a link between Type 2 diabetes and Alzheimer's disease.

Authors:  Michal Baram; Yoav Atsmon-Raz; Buyong Ma; Ruth Nussinov; Yifat Miller
Journal:  Phys Chem Chem Phys       Date:  2016-01-28       Impact factor: 3.676

9.  Synergistic interactions between repeats in tau protein and Aβ amyloids may be responsible for accelerated aggregation via polymorphic states.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Biochemistry       Date:  2011-05-18       Impact factor: 3.162

10.  Aβ(1-42) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer's disease.

Authors:  Yiling Xiao; Buyong Ma; Dan McElheny; Sudhakar Parthasarathy; Fei Long; Minako Hoshi; Ruth Nussinov; Yoshitaka Ishii
Journal:  Nat Struct Mol Biol       Date:  2015-05-04       Impact factor: 15.369

View more
  18 in total

Review 1.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

Review 2.  Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases.

Authors:  Anna Villar-Piqué; Matthias Schmitz; Niccolò Candelise; Salvador Ventura; Franc Llorens; Inga Zerr
Journal:  Mol Neurobiol       Date:  2018-02-10       Impact factor: 5.590

Review 3.  Amyloid β structural polymorphism, associated toxicity and therapeutic strategies.

Authors:  Ofek Oren; Ran Taube; Niv Papo
Journal:  Cell Mol Life Sci       Date:  2021-10-13       Impact factor: 9.261

4.  Depletion of amyloid-β peptides from solution by sequestration within fibril-seeded hydrogels.

Authors:  Wai-Ming Yau; Robert Tycko
Journal:  Protein Sci       Date:  2018-03-08       Impact factor: 6.725

Review 5.  Half a century of amyloids: past, present and future.

Authors:  Pu Chun Ke; Ruhong Zhou; Louise C Serpell; Roland Riek; Tuomas P J Knowles; Hilal A Lashuel; Ehud Gazit; Ian W Hamley; Thomas P Davis; Marcus Fändrich; Daniel Erik Otzen; Matthew R Chapman; Christopher M Dobson; David S Eisenberg; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2020-07-07       Impact factor: 54.564

6.  Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.

Authors:  Lei Gu; Zhefeng Guo
Journal:  Biochem Biophys Res Commun       Date:  2020-12-01       Impact factor: 3.575

Review 7.  The existence of Aβ strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease.

Authors:  Heather H C Lau; Martin Ingelsson; Joel C Watts
Journal:  Acta Neuropathol       Date:  2020-08-02       Impact factor: 17.088

8.  A mix-and-click method to measure amyloid-β concentration with sub-micromolar sensitivity.

Authors:  Christine Xue; Yoon Kyung Lee; Joyce Tran; Dennis Chang; Zhefeng Guo
Journal:  R Soc Open Sci       Date:  2017-08-09       Impact factor: 2.963

9.  Amyloid β-peptides 1-40 and 1-42 form oligomers with mixed β-sheets.

Authors:  Maurizio Baldassarre; Cesare M Baronio; Ludmilla A Morozova-Roche; Andreas Barth
Journal:  Chem Sci       Date:  2017-10-12       Impact factor: 9.825

10.  Should the Treatment of Amyloidosis Be Personified? Molecular Mechanism of Amyloid Formation by Aβ Peptide and Its Fragments.

Authors:  Oxana V Galzitskaya; Alexey K Surin; Anna V Glyakina; Vadim V Rogachevsky; Olga M Selivanova
Journal:  J Alzheimers Dis Rep       Date:  2018-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.